Genetic Code Expansion Enables Site-Specific PEGylation of a Human Growth Hormone Receptor Antagonist through Click Chemistry.

Abstract

Regulation of human growth hormone (GH) signaling has important applications in the remediation of several diseases including acromegaly and cancer. Growth hormone receptor (GHR) antagonists currently provide the most effective means for suppression of GH signaling. However, these small 22 kDa recombinantly engineered GH analogues exhibit short plasma circulation times. To improve clinical viability, between four and six molecules of 5 kDa poly(ethylene glycol) (PEG) are nonspecifically conjugated to the nine amines of the GHR antagonist designated as B2036 in the FDA-approved therapeutic pegvisomant. PEGylation increases the molecular weight of B2036 and considerably extends its circulation time, but also dramatically reduces its bioactivity, contributing to high dosing requirements and increased cost. As an alternative to nonspecific PEGylation, we report the use of genetic code expansion technology to site-specifically incorporate the unnatural amino acid propargyl tyrosine (pglY) into B2036 with the goal of producing site-specific protein-polymer conjugates. Substitution of tyrosine 35 with pglY yielded a B2036 variant containing an alkyne functional group without compromising bioactivity, as verified by a cellular assay. Subsequent conjugation of 5, 10, and 20 kDa azide-containing PEGs via the copper-catalyzed click reaction yielded high purity, site-specific conjugates with >89% conjugation efficiencies. Site-specific attachment of PEG to B2036 is associated with substantially improved in vitro bioactivity values compared to pegvisomant, with an inverse relationship between polymer size and activity observed. Notably, the B2036-20 kDa PEG conjugate has a molecular weight comparable to pegvisomant, while exhibiting a 12.5 fold improvement in half-maximal inhibitory concentration in GHR-expressing Ba/F3 cells (103.3 nM vs 1289 nM). We expect that this straightforward route to achieve site-specific GHR antagonists will be useful for GH signal regulation.

• Authors: Kyle Tamshen, Yue Wang, Stephen M F Jamieson, Jo K Perry, Heather D Maynard
• Journal: Bioconjugate chemistry (Bioconjug Chem) Vol. 31 Issue 9 Pg. 2179-2190 (09 16 2020) ISSN: 1520-4812 [Electronic] United States
• PMID: 32786367 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• Azides
• Human Growth Hormone
• Polyethylene Glycols
• Tyrosine
• Copper
• pegvisomant

Topics

• Azides (chemistry)
• Catalysis
• Click Chemistry
• Copper (chemistry)
• Genetic Code
• Human Growth Hormone (analogs & derivatives, chemistry, genetics)
• Humans
• Polyethylene Glycols (chemistry)
• Tyrosine (analogs & derivatives, genetics)